0
0
9/28/22 at 8:43pm
Organization
Ajmc.com
42 words
0
Comments
Joshua Sabari, MD, a thoracic medical oncologist, Perlmutter Cancer Center, NYU Langone Health, discusses actionable mutations in advanced non–small cell lung cancer (NSCLC).
You are the first to view
https://www.ajmc.com/view/dr-joshua-sabari-on-burden-treatment-options-for-patients-with-kras-mutated-nsclc
Create an account
or login to join the discussion